NEW YORK (GenomeWeb) – Nanosphere reported after the close of the market Wednesday that its fourth quarter net loss increased to $9.5 million, or $.08 per share, from $8.8 million, or $.11 per share, for the fourth quarter of 2013, as the firm continues to evaluate strategic alternatives.

Its loss per share beat the consensus Wall Street estimate of $.10.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.